Australia markets closed

Comera Life Sciences Holdings, Inc. (CMRA)

OTC Markets EXMKT - OTC Markets EXMKT Delayed price. Currency in USD
Add to watchlist
0.02220.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 682.38k
Enterprise value -913.89k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.43
Price/book (mrq)N/A
Enterprise value/revenue 39.74
Enterprise value/EBITDA -1.28

Trading information

Stock price history

Beta (5Y monthly) 0.03
52-week change 3-93.74%
S&P500 52-week change 326.33%
52-week high 30.4666
52-week low 30.0212
50-day moving average 30.0228
200-day moving average 30.0388

Share statistics

Avg vol (3-month) 32.09k
Avg vol (10-day) 3N/A
Shares outstanding 530.74M
Implied shares outstanding 630.74M
Float 88.56M
% held by insiders 170.47%
% held by institutions 19.93%
Shares short (31 Oct 2023) 4281.55k
Short ratio (31 Oct 2023) 40.84
Short % of float (31 Oct 2023) 41.36%
Short % of shares outstanding (31 Oct 2023) 40.92%
Shares short (prior month 29 Sept 2023) 427.93k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 3�
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,582.47%

Management effectiveness

Return on assets (ttm)-119.35%
Return on equity (ttm)-1,629.02%

Income statement

Revenue (ttm)1M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)-42.00%
Gross profit (ttm)N/A
EBITDA -7.55M
Net income avi to common (ttm)-9.35M
Diluted EPS (ttm)-0.2200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.77M
Total cash per share (mrq)0.06
Total debt (mrq)561.47k
Total debt/equity (mrq)549.04%
Current ratio (mrq)0.90
Book value per share (mrq)-0.14

Cash flow statement

Operating cash flow (ttm)-6.66M
Levered free cash flow (ttm)-2.99M